Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

Clinical trial NCT01413191 · COMPLETED

Trial details

NCT number: NCT01413191
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Iris Melanoma Metastatic Intraocular Melanoma Recurrent Intraocular Melanoma Stage IV Intraocular Melanoma

Start date: 2011-08-01
Primary completion: 2013-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.